| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4HSZ1
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_MEL_PAP_1 | 71 | 77 | PF00089 | 0.400 |
| CLV_NRD_NRD_1 | 63 | 65 | PF00675 | 0.352 |
| CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.417 |
| CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.390 |
| CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.355 |
| DOC_ANK_TNKS_1 | 72 | 79 | PF00023 | 0.591 |
| DOC_MAPK_gen_1 | 48 | 57 | PF00069 | 0.529 |
| DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.340 |
| DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.297 |
| DOC_WW_Pin1_4 | 101 | 106 | PF00397 | 0.666 |
| DOC_WW_Pin1_4 | 114 | 119 | PF00397 | 0.603 |
| LIG_14-3-3_CanoR_1 | 108 | 114 | PF00244 | 0.616 |
| LIG_FHA_1 | 2 | 8 | PF00498 | 0.469 |
| LIG_FHA_1 | 66 | 72 | PF00498 | 0.579 |
| LIG_LIR_Apic_2 | 98 | 103 | PF02991 | 0.671 |
| LIG_LIR_Nem_3 | 38 | 43 | PF02991 | 0.330 |
| LIG_SH2_CRK | 100 | 104 | PF00017 | 0.671 |
| LIG_SH2_CRK | 3 | 7 | PF00017 | 0.478 |
| LIG_SH2_GRB2like | 56 | 59 | PF00017 | 0.548 |
| LIG_SH2_NCK_1 | 100 | 104 | PF00017 | 0.671 |
| LIG_SH2_STAP1 | 3 | 7 | PF00017 | 0.495 |
| LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.401 |
| LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.539 |
| LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.552 |
| LIG_SH2_STAT5 | 56 | 59 | PF00017 | 0.564 |
| LIG_SH3_1 | 115 | 121 | PF00018 | 0.475 |
| LIG_SH3_3 | 115 | 121 | PF00018 | 0.462 |
| LIG_SH3_3 | 6 | 12 | PF00018 | 0.388 |
| LIG_SUMO_SIM_par_1 | 129 | 136 | PF11976 | 0.318 |
| LIG_WW_3 | 108 | 112 | PF00397 | 0.672 |
| MOD_CDK_SPxxK_3 | 101 | 108 | PF00069 | 0.607 |
| MOD_CK1_1 | 104 | 110 | PF00069 | 0.627 |
| MOD_CK1_1 | 132 | 138 | PF00069 | 0.300 |
| MOD_CK1_1 | 149 | 155 | PF00069 | 0.423 |
| MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.466 |
| MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.305 |
| MOD_GlcNHglycan | 86 | 90 | PF01048 | 0.497 |
| MOD_GSK3_1 | 129 | 136 | PF00069 | 0.415 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.632 |
| MOD_NEK2_1 | 129 | 134 | PF00069 | 0.312 |
| MOD_NEK2_1 | 67 | 72 | PF00069 | 0.588 |
| MOD_NEK2_2 | 28 | 33 | PF00069 | 0.333 |
| MOD_NEK2_2 | 35 | 40 | PF00069 | 0.404 |
| MOD_Plk_4 | 2 | 8 | PF00069 | 0.493 |
| MOD_Plk_4 | 28 | 34 | PF00069 | 0.303 |
| MOD_Plk_4 | 35 | 41 | PF00069 | 0.412 |
| MOD_ProDKin_1 | 101 | 107 | PF00069 | 0.664 |
| MOD_ProDKin_1 | 114 | 120 | PF00069 | 0.599 |
| TRG_ENDOCYTIC_2 | 3 | 6 | PF00928 | 0.512 |
| TRG_ER_diArg_1 | 47 | 50 | PF00400 | 0.522 |
| TRG_ER_diArg_1 | 71 | 74 | PF00400 | 0.587 |
| TRG_Pf-PMV_PEXEL_1 | 148 | 153 | PF00026 | 0.612 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PBL5 | Leptomonas seymouri | 40% | 100% |
| A0A3S7WPM7 | Leishmania donovani | 99% | 100% |
| E9AI23 | Leishmania braziliensis | 61% | 100% |
| E9AKX8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| Q4QIX7 | Leishmania major | 94% | 100% |